Mediwatch PLC Form 8 (OPD) Mediwatch plc (9948R)
01 November 2013 - 10:12PM
UK Regulatory
TIDMMDW
RNS Number : 9948R
Mediwatch PLC
01 November 2013
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Identity of the party to the offer making the disclosure: Mediwatch plc
--------------------------------------------------------------------------------------------- ----------------
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A
The naming of nominee or vehicle companies is insufficient
--------------------------------------------------------------------------------------------- ----------------
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Mediwatch plc
Use a separate form for each party to the offer
--------------------------------------------------------------------------------------------- ----------------
(d) Is the party to the offer making the disclosure the offeror or the offeree? OFFEREE
--------------------------------------------------------------------------------------------- ----------------
(e) Date position held: 1 November 2013
--------------------------------------------------------------------------------------------- ----------------
(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect NO
of any other party to this offer?
--------------------------------------------------------------------------------------------- ----------------
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: 1p Ordinary Shares
------------------------------------------------- --------------------------------
Interests Short positions
------------------------------------------------- ------------ ------------------
Number % Number %
------------------------------------------------- -------- ------------- ---
(1) Relevant securities owned and/or controlled: Nil - Nil -
------------------------------------------------- -------- ------------- ---
(2) Derivatives (other than options): Nil - Nil -
------------------------------------------------- -------- ------------- ---
(3) Options and agreements to purchase/sell: Nil - Nil -
------------------------------------------------- -------- ------------- ---
Nil - Nil -
TOTAL:
------------------------------------------------- -------- ------------- ---
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or
agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or
financial collateral arrangements should be disclosed on a
Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: None
---------------------------------------------------------------------------- -----
Details, including nature of the rights concerned and relevant percentages: None
---------------------------------------------------------------------------- -----
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(c) Irrevocable commitments and letters of intent
Details of any irrevocable commitments or letters of intent procured by the party to the offer
making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of
the Code):
-----------------------------------------------------------------------------------------------
None
-----------------------------------------------------------------------------------------------
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe of any person acting in
concert with the party to the offer making the disclosure:
------------------------------------------------------------------------------------------------------
Name Number of Ordinary Percentage of Ordinary
Shares held Shares held
------------------ ------------------- -----------------------
Philip Stimpson 24,418,021 17.33
------------------ ------------------- -----------------------
Omer Karim (1) 9,884,450 7.02
------------------ ------------------- -----------------------
Mark Emberton 2,615,386 1.86
------------------ ------------------- -----------------------
Charles Cattaneo
(2) 1,400,000 0.99
------------------ ------------------- -----------------------
Mark Hughes 150,000 0.11
------------------ ------------------- -----------------------
Name Options to Exercise Expiry Date
purchase shares Price (pence)
----------------- ----------------- --------------- ------------
Philip Stimpson 1,200,000 5.25 20.08.2020
----------------- ----------------- --------------- ------------
350,000 7.25 05.05.2019
----------------- ----------------- --------------- ------------
Total 1,550,000
----------------- ----------------- --------------- ------------
(1) Omer Karim's interest includes (i) 5,224,831 Ordinary Shares held in a nominee account
by Harbour Limited for an Off-Shore Trust Fund, the beneficiaries of which are Mr Karim and
his immediate family, (ii) 3,471,354 Ordinary Shares held through his Self Invested Personal
Pension ("SIPP") and (iii) 288,821 Ordinary Shares beneficially owned by Mrs H Karim, of which
142,692 Ordinary Shares are held through her SIPP
(2) Charles Cattaneo's interest includes 840,000 Ordinary Shares held through his SIPP
------------------------------------------------------------------------------------------------------
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 3 for each additional class of
relevant security.
Details of any open derivative or option positions, or
agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or
financial collateral arrangements should be disclosed on a
Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the party to the offer making the disclosure or any person acting
in concert with it:
If there are no such agreements, arrangements or understandings, state "none"
------------------------------------------------------------------------------------------------
None
------------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the party
to the offer making the disclosure, or any person acting in concert with it, and any other
person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
----------------------------------------------------------------------------------------------
None
----------------------------------------------------------------------------------------------
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
------------------------------------- ---
Supplemental Form 8 (SBL) NO
------------------------------------- ---
Date of disclosure: 1 November 2013
--------------------- -------------------
Contact name: Mark Hughes
--------------------- -------------------
Telephone number: +44 (0)1788 547888
--------------------- -------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market
Surveillance Unit is available for consultation in relation to the
Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEEEAFFFEENDFFF
Mediwatch (LSE:MDW)
Historical Stock Chart
From May 2024 to Jun 2024
Mediwatch (LSE:MDW)
Historical Stock Chart
From Jun 2023 to Jun 2024